Metformin as an Anti-Aging Drug [Video]

In this episode of Atria’s Vanguard Symposia, leading gerontologist Dr. Nir Barzilai unpacks the science of aging. He redefines aging as a modifiable process rather than a mere chronology, and explores how genetics, biology, and pharmacology impact lifespan and healthspan. Dr. Barzilai spotlights metformin, a diabetes drug showing promise in disrupting the aging process. He also shares insights from his TAME (Targeting Aging with Metformin) study, which aims to prove metformin can delay multiple age-related diseases, potentially transforming how we approach longevity.

Atria’s Vanguard Symposia is a lecture series where some of the world’s most compelling researchers translate leading-edge science into medicine. In each episode, top experts share breakthrough science about preventive health care, dive deep into headline-grabbing topics, and take you beyond the buzzwords to explain the latest in longevity science. Our show will arm you with practical information and the tools of discernment to cut through the hype and understand what matters most.

Atria Health and Research Institute aims to accelerate a global shift from reactive sick care to proactive, preventive health care. We work at the forefront of science and technology and we believe a collaborative approach to modern medicine can extend healthy life for all.